Clinical Research: Outcome of Home Enteral Nutrition in Patients with Malignant Dysphagia

Mark Schattner, Rafael Barrera, Stephen Nygard, Faye Scott, Ofelia Quesada, Patricia Brown, Moshe Shike

Nutrition in Clinical Practice · 2001 · 14 citations · 19 references

Concepts

Abstract

Neoplastic diseases account for approximately one‐half of all patients receiving home enteral nutrition, most of them with dysphagia due to the underlying cancer or antineoplastic therapies (malignant dysphagia). A review of the records of all patients with malignant dysphagia receiving home enteral nutrition for greater than 1 year was undertaken. The following factors were identified: age, primary cancer, type of enteral access, calories received, duration of therapy, complications, and need for tube replacement. Eighty‐two patients were studied. On average, patients received 1978 cal/day (range: 500 to 3000) and were maintained on home enteral nutrition for 976 days (range: 367 to 3026). Complications at the tube site were infection in 4 patients (4.8%) and significant leakage in 2 patients (2.4%). Average durability of the enteral access devices was percutaneous endoscopic gastrostomies (PEG) = 690 days, low profile gastrostomy = 1701 days, percutaneous endoscopic jejunostomies (PEJ) = 591 days, low‐profile jejunostomy = 902 days, and surgical jojunostomy = 1114 days. Home enteral nutrition is a safe and effective means of long‐term nutritional support in patients with severe malignant dysphagia.

References

19